These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 33627802)
1. 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis. Pan RY; Kong XX; Cheng Y; Du L; Wang ZC; Yuan C; Cheng JB; Yuan ZQ; Zhang HY; Liao YJ Acta Pharmacol Sin; 2021 Nov; 42(11):1769-1779. PubMed ID: 33627802 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. Wang X; Li B; Liu L; Zhang L; Ma T; Guo L Int Immunopharmacol; 2021 Jan; 90():107092. PubMed ID: 33290962 [TBL] [Abstract][Full Text] [Related]
3. Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases. Chen C; Zhou Y; Ning X; Li S; Xue D; Wei C; Zhu Z; Sheng L; Lu B; Li Y; Ye X; Fu Y; Bai C; Cai W; Ding Y; Lin S; Yan G; Huang Y; Yin W J Neuroinflammation; 2022 Dec; 19(1):315. PubMed ID: 36577999 [TBL] [Abstract][Full Text] [Related]
4. Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis. Guo C; Fulp JW; Jiang Y; Li X; Chojnacki JE; Wu J; Wang XY; Zhang S ACS Chem Neurosci; 2017 Oct; 8(10):2194-2201. PubMed ID: 28653829 [TBL] [Abstract][Full Text] [Related]
5. Inflammasome activation in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Barclay W; Shinohara ML Brain Pathol; 2017 Mar; 27(2):213-219. PubMed ID: 27997058 [TBL] [Abstract][Full Text] [Related]
6. Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1. Ke P; Shao BZ; Xu ZQ; Chen XW; Wei W; Liu C CNS Neurosci Ther; 2017 Nov; 23(11):875-884. PubMed ID: 28941191 [TBL] [Abstract][Full Text] [Related]
7. Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages. Hung YL; Wang SC; Suzuki K; Fang SH; Chen CS; Cheng WC; Su CC; Yeh HC; Tu HP; Liu PL; Huang MY; Li CY Phytomedicine; 2019 Jun; 59():152785. PubMed ID: 31009850 [TBL] [Abstract][Full Text] [Related]
9. Caffeine Inhibits Activation of the NLRP3 Inflammasome via Autophagy to Attenuate Microglia-Mediated Neuroinflammation in Experimental Autoimmune Encephalomyelitis. Wang HQ; Song KY; Feng JZ; Huang SY; Guo XM; Zhang L; Zhang G; Huo YC; Zhang RR; Ma Y; Hu QZ; Qin XY J Mol Neurosci; 2022 Jan; 72(1):97-112. PubMed ID: 34478049 [TBL] [Abstract][Full Text] [Related]
10. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. Shao BZ; Wei W; Ke P; Xu ZQ; Zhou JX; Liu C CNS Neurosci Ther; 2014 Dec; 20(12):1021-8. PubMed ID: 25417929 [TBL] [Abstract][Full Text] [Related]
11. AZD8055 ameliorates experimental autoimmune encephalomyelitis via the mTOR/ROS/NLRP3 pathway. He M; Wu DM; Zhao YY; Yu Y; Deng SH; Liu T; Zhang T; Li J; Wang F; Xu Y Biochem Biophys Res Commun; 2021 Oct; 573():27-34. PubMed ID: 34384953 [TBL] [Abstract][Full Text] [Related]
13. Brevilin A inhibits NLRP3 inflammasome activation in vivo and in vitro by acting on the upstream of NLRP3-induced ASC oligomerization. Qin Q; Xu G; Zhan X; Wang Z; Wang Y; Liu H; Hou X; Shi W; Ma J; Bai Z; Xiao X Mol Immunol; 2021 Jul; 135():116-126. PubMed ID: 33892379 [TBL] [Abstract][Full Text] [Related]
14. GPR40 agonist inhibits NLRP3 inflammasome activation via modulation of nuclear factor-κB and sarco/endoplasmic reticulum Ca Park J; Lee MY; Seo YS; Kang B; Lim SC; Kang KW Life Sci; 2021 Dec; 287():120127. PubMed ID: 34774873 [TBL] [Abstract][Full Text] [Related]
15. Safranal inhibits NLRP3 inflammasome activation by preventing ASC oligomerization. Gupta M; Wani A; Ahsan AU; Ali M; Chibber P; Singh S; Digra SK; Datt M; Bharate SB; Vishwakarma RA; Singh G; Kumar A Toxicol Appl Pharmacol; 2021 Jul; 423():115582. PubMed ID: 34019860 [TBL] [Abstract][Full Text] [Related]
16. Dehydrocostus lactone inhibits NLRP3 inflammasome activation by blocking ASC oligomerization and prevents LPS-mediated inflammation in vivo. Chen Y; Li R; Wang Z; Hou X; Wang C; Ai Y; Shi W; Zhan X; Wang JB; Xiao X; Bai Z; Sun H; Xu G Cell Immunol; 2020 Mar; 349():104046. PubMed ID: 32057354 [TBL] [Abstract][Full Text] [Related]
17. Acetylase inhibitor SI-2 is a potent anti-inflammatory agent by inhibiting NLRP3 inflammasome activation. Liu L; Xu X; Zhang N; Zhang Y; Zhao K Int Immunopharmacol; 2020 Oct; 87():106829. PubMed ID: 32736194 [TBL] [Abstract][Full Text] [Related]
18. Bixin Attenuates Experimental Autoimmune Encephalomyelitis by Suppressing TXNIP/NLRP3 Inflammasome Activity and Activating NRF2 Signaling. Yu Y; Wu DM; Li J; Deng SH; Liu T; Zhang T; He M; Zhao YY; Xu Y Front Immunol; 2020; 11():593368. PubMed ID: 33362775 [TBL] [Abstract][Full Text] [Related]
19. Sinapic Acid Controls Inflammation by Suppressing NLRP3 Inflammasome Activation. Lee EH; Shin JH; Kim SS; Seo SR Cells; 2021 Sep; 10(9):. PubMed ID: 34571975 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype. Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]